Amedisys Inc (AMED) - Total Assets

Latest as of June 2025: $2.22 Billion USD

Based on the latest financial reports, Amedisys Inc (AMED) holds total assets worth $2.22 Billion USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Amedisys Inc's book value for net asset value and shareholders' equity analysis.

Amedisys Inc - Total Assets Trend (1993–2024)

This chart illustrates how Amedisys Inc's total assets have evolved over time, based on quarterly financial data.

Amedisys Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Amedisys Inc's total assets of $2.22 Billion consist of 29.6% current assets and 70.5% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 14.2%
Accounts Receivable $308.07 Million 14.4%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $81.16 Million 3.8%
Goodwill $1.21 Billion 56.8%

Asset Composition Trend (1993–2024)

This chart illustrates how Amedisys Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Amedisys Inc market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Amedisys Inc's current assets represent 29.6% of total assets in 2024, a decrease from 81.4% in 1993.
  • Cash Position: Cash and equivalents constituted 14.2% of total assets in 2024, down from 25.6% in 1993.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 0.0% in 1993.
  • Asset Diversification: The largest asset category is goodwill at 56.8% of total assets.

Amedisys Inc Competitors by Total Assets

Key competitors of Amedisys Inc based on total assets are shown below.

Company Country Total Assets
Chemed Corp
NYSE:CHE
USA $1.62 Billion
Top Choice Medical Investment Co Inc
SHG:600763
China CN¥6.28 Billion
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
Indonesia Rp8.99 Trillion
Oceania Healthcare Ltd
AU:OCA
Australia AU$3.01 Billion
Ramsay Health Care Ltd
AU:RHC
Australia AU$22.48 Billion
Regis Healthcare Ltd
AU:REG
Australia AU$2.11 Billion
Pacific Smiles Group Ltd
AU:PSQ
Australia AU$163.53 Million
Freedom Care Group Holdings Ltd
AU:FCG
Australia AU$9.86 Million

Amedisys Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.36 1.16 0.94
Quick Ratio 1.36 1.16 0.90
Cash Ratio 0.00 0.00 0.00
Working Capital $173.84 Million $75.93 Million $-26.25 Million

Amedisys Inc - Advanced Valuation Insights

This section examines the relationship between Amedisys Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.69
Latest Market Cap to Assets Ratio 1.55
Asset Growth Rate (YoY) 3.8%
Total Assets $2.14 Billion
Market Capitalization $3.32 Billion USD

Valuation Analysis

Above Book Valuation: The market values Amedisys Inc's assets above their book value (1.55x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Amedisys Inc's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Amedisys Inc (1993–2024)

The table below shows the annual total assets of Amedisys Inc from 1993 to 2024.

Year Total Assets Change
2024-12-31 $2.14 Billion +3.81%
2023-12-31 $2.06 Billion +4.25%
2022-12-31 $1.98 Billion +6.42%
2021-12-31 $1.86 Billion +18.49%
2020-12-31 $1.57 Billion +24.11%
2019-12-31 $1.26 Billion +76.09%
2018-12-31 $717.12 Million -11.85%
2017-12-31 $813.48 Million +10.82%
2016-12-31 $734.03 Million +7.14%
2015-12-31 $685.09 Million +2.29%
2014-12-31 $669.74 Million -7.80%
2013-12-31 $726.41 Million -0.57%
2012-12-31 $730.60 Million -14.88%
2011-12-31 $858.28 Million -33.97%
2010-12-31 $1.30 Billion +10.87%
2009-12-31 $1.17 Billion +9.55%
2008-12-31 $1.07 Billion +82.28%
2007-12-31 $587.11 Million +26.60%
2006-12-31 $463.76 Million +36.40%
2005-12-31 $340.00 Million +70.23%
2004-12-31 $199.73 Million +115.99%
2003-12-31 $92.47 Million +58.55%
2002-12-31 $58.32 Million +22.43%
2001-12-31 $47.64 Million +14.60%
2000-12-31 $41.57 Million -1.22%
1999-12-31 $42.08 Million -5.28%
1998-12-31 $44.43 Million +94.26%
1997-12-31 $22.87 Million +35.66%
1996-12-31 $16.86 Million +46.60%
1995-12-31 $11.50 Million +82.54%
1994-12-31 $6.30 Million +46.51%
1993-12-31 $4.30 Million --

About Amedisys Inc

NASDAQ:AMED USA Medical Care Facilities
Market Cap
$3.32 Billion
Market Cap Rank
#4634 Global
#1495 in USA
Share Price
$100.99
Change (1 day)
+0.01%
52-Week Range
$93.43 - $100.99
All Time High
$314.16
About

Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more